Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes [NA]
A clinical trial is assessing the effects of a low glycemic load diet on dysglycemia and body composition in adults with cystic fibrosis-rel…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: A Study Assessing KB407 for the Treatment of Cystic Fibrosis [Phase 1]
A Phase 1 clinical trial evaluating KB407 for cystic fibrosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Project 2 Airway Potential Hydrogen (pH) in Asthma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating airway pH in patients with cystic fibrosis and asthma, sponsored by Case Western Reserve Uni…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Baby Detect : Genomic Newborn Screening
Clinical trial update on the Baby Detect genomic newborn screening program, reporting completion of a study assessing screening for multiple…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: The Alfred Step Test Exercise Protocol (A-STEP), for Adults With Cystic Fibrosis. [NA]
The Alfred Step Test Exercise Protocol (A-STEP) trial for adults with cystic fibrosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy Subjects [Phase 1]
Phase 1 trial update reporting completion of a single- and multiple-ascending-dose study of KIT2014 in healthy subjects. The study lists Cys…
-
EMA approval · 2025-08-04EMA Authorised: Kalydeco (ivacaftor) — Vertex Pharmaceuticals (Ireland) Limited
The EMA authorised Kalydeco (ivacaftor) for cystic fibrosis under accelerated assessment in the European Union. The decision date was 04/04/…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: YOGA-CF (Yoga Outcomes Get Assessed in Cystic Fibrosis) [NA]
The YOGA-CF trial investigating yoga outcomes in cystic fibrosis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis [NA]
A clinical trial is currently recruiting to evaluate the CGM Dynamic Index for predicting prediabetes in people with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions [NA]
Completed clinical trial results have been posted for the Peer i-Coaching program, evaluating activated self-management optimization in adol…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Effectiveness of Respiratory Physiotherapy on Frequency of Exacerbations, Lung Function and Quality of Life After 6 Months in Children With Cystic Fibrosis [NA]
A completed clinical trial evaluating the effectiveness of respiratory physiotherapy on exacerbations, lung function, and quality of life ov…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Genetics of Insulin and Incretins in Cystic Fibrosis
A clinical study investigating how genetic variation affects insulin and incretin pathways in people with cystic fibrosis; the trial is curr…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Study With Phage for CF Subjects With Pseudomonas Lung Infection [Phase 2]
A Phase 2 clinical trial sponsored by BiomX Ltd is evaluating phage therapy for chronic Pseudomonas aeruginosa lung infection in people with…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)
A clinical trial sponsored by Emory University is evaluating how body fat distribution influences metabolic and pulmonary decline in people …
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating nebulized bacteriophage therapy for chronic Pseudomonas aeruginosa lung infection in cystic fibrosis p…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
A completed clinical trial update from Erasmus Medical Center focusing on monitoring inflammation in cystic fibrosis lung disease as part of…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: COVID-19 Antibody Responses In Cystic Fibrosis
A clinical trial evaluating COVID-19 antibody responses in individuals with Cystic Fibrosis has completed.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Comparative Effects of Mechanical and Manual Airway Clearance Techniques in Cystic Fibrosis [NA]
This clinical trial update describes a planned comparative study of mechanical versus manual airway clearance techniques in cystic fibrosis,…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis [NA]
An update on implementing a clinical tool intended to reduce waitlist mortality in cystic fibrosis patients awaiting lung transplantation, w…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis
The document updates a clinical trial investigating cellular markers in treated or untreated non-tuberculous mycobacterial respiratory infec…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis [EARLY_Phase 1]
An early Phase 1 clinical trial assessing non-pulmonary contributors to exercise intolerance in cystic fibrosis has completed. The study was…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
This clinical trial update describes the TIDES 2.0 study, which assesses the prevalence and longitudinal course of depression, anxiety, and …
-
CLINICAL_TRIALS withdrawal · 2025-06-27Clinical Trial Update: Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis [Phase 2, Phase 3]
A Phase 2/3 trial evaluating rifaximin for bloating in cystic fibrosis patients has been withdrawn. The document records the withdrawal of t…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Remote Exercise to Improve Physical Activity Levels and Markers of Heart Health in Cystic Fibrosis (RHH-CF) [NA]
This clinical trial explores remote exercise to boost physical activity and improve heart health markers in people with cystic fibrosis; the…
-
EMA approval · 2025-06-20EMA Authorised: Colobreathe (Colistimethate sodium) — Essential Pharma Limited
The EMA authorised Colobreathe, a colistimethate sodium inhalation product for cystic fibrosis, with Essential Pharma Limited as the marketi…